1 October 2020 in Cell Reports
Polymyxin resistance (PR) threatens the treatment of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. PR frequently arises through chemical modification of the lipid A portion of lipopolysaccharide. Various mutations are implicated in PR, including in three two-component systems—CrrA/B, PmrA/B, and PhoP/Q—and the negative regulator MgrB. Few have been functionally validated. Therefore, here we adapt a CRISPR-Cas9 system to CRKP to elucidate how mutations in clinical CRKP isolates induce PR. We demonstrate that CrrB is a positive regulator of PR, and common clinical mutations lead to the addition of both 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosophethanolamine (pEtN) to lipid A, inducing notably higher polymyxin minimum inhibitory concentrations than mgrB disruption. Additionally, crrB mutations cause a significant virulence increase at a fitness cost, partially from activation of the pentose phosphate pathway. Our data demonstrate the importance of CrrB in high-level PR and establish important differences across crrB alleles in balancing resistance with fitness and virulence.
14 September 2017 in Molecular Microbiology
26 November 2025 in Nature Communications
Polymyxins are used to treat infections caused by multidrug-resistant Gram-negative bacteria. They are cationic peptides that target the negatively charged lipid A component of lipopolysaccharides, disrupting the outer membrane and lysing the cell. Polymyxin resistance is conferred by inner-membrane enzymes, such as phosphoethanolamine transferases, which add positively charged phosphoethanolamine to lipid A. Here, we present the structure of MCR-1, a plasmid-encoded phosphoethanolamine transferase, in its liganded form. The phosphatidylethanolamine donor substrate is bound near the active site in the periplasmic domain, and lipid A is bound over 20 Å away, within the transmembrane region. Integrating structural, biochemical, and drug-resistance data with computational analyses, we propose a two-state model in which the periplasmic domain rotates to bring the active site to lipid A, near the preferential phosphate modification site for MCR-1. This enzymatic mechanism may be generally applicable to other phosphoform transferases with large, globular soluble domains.
2 June 2026 in Nature Communications
Symbiotic bacteria in the gut have an important physiological impact on their hosts, but the mechanisms that underlie the exchange of molecular signals remain poorly understood. Membrane vesicles have been suggested to mediate the direct exchange of cytoplasmic content like nucleic acids (NAs), but their study is complicated by conflicting and imprecise reports of their type and composition. Here, we show that honeybee gut symbionts produce non-lytic membrane vesicles (MVs) enriched in NA, potentially explaining the RNAi activity of engineered Snodgrassella alvi in honeybees. Using cryogenic electron microscopy (cryo-EM), we developed a method to distinguish lytic from non-lytic MV production in Gram-negative bacteria and to differentiate outer membrane vesicles (OMVs) from outer-inner membrane vesicles (OIMVs) based on membrane ultrastructure. Among the strains studied, S. alvi, Gilliamella apicola, and Gilliamella apis exhibit clear OMV and OIMV budding, while Escherichia coli and Salmonella enterica show membrane debris and self-assembled vesicles, indicating lytic release. MVs from the symbionts carry significantly more NAs than non-symbionts. Assays on DNA and RNA contents confirm the cytoplasmic origin of MV cargo in S. alvi, suggesting a role in mediating NA delivery to the insect host. These findings enhance our understanding of symbiotic vesiculation and highlight the potential for engineering symbionts to boost honeybee immunity and deliver NA-based therapeutics via vesicular transport.
22 January 2026 in Proceedings of the National Academy of Sciences
Gram-negative bacteria have long been thought to confine primary glycerophospholipid synthesis to the inner membrane (IM). Here, we challenge this paradigm by identifying ClsO, an outer membrane (OM) lipoprotein from Acinetobacter baumannii that functions as a cardiolipin synthase. In contrast to canonical cardiolipin synthases, which are restricted to the IM, ClsO is surface-exposed and deposits cardiolipin into the outer leaflet of the OM, colocalizing with Acinetobacter lipooligosaccharide. Loss of ClsO sensitizes cells to membrane disrupting agents, such as bile salts, and key antibiotics, implicating ClsO in OM barrier integrity. ClsO activity increases when mislocalized glycerophospholipids accumulate at the cell surface, such as in cells lacking Mla (maintenance of lipid asymmetry) system, consistent with a surface-active site mechanism. Engineering mutations in ClsO that prevent its trafficking to the OM was found to abolish nearly all enzymatic activity. Remarkably, we found that ClsO homologs are widespread across Proteobacteria and confirmed several to be functional cardiolipin synthases, indicating a conserved strategy of surface lipid remodeling. These findings redefine the spatial organization of lipid metabolism in Gram-negative bacteria and reveal an adaptive mechanism to maintain OM integrity when membrane asymmetry is compromised.
10 October 2025 in bioRxiv
Multi-drug resistant Gram-negative bacteria, including carbapenem-resistant Klebsiella pneumoniae (CR Kp ), are a public health emergency. The predominant CR Kp sequence type worldwide is ST258. However, the factors underlying ST258’s epidemic success are not well defined. The understudied two-component system CrrAB is a genomic feature of ST258 and has been hypothesized to contribute to its global dominance. Despite this, the molecular details underpinning CrrAB’s contribution to ST258 pathogenicity are not well understood. We used RNA-sequencing to identify the regulon of CrrA and found that CrrAB induces the expression of a novel gene, encoding Crr-regulated fimbriae modifying protein (CfmP). CfmP post-translationally modifies fimbriae to significantly increase host cell adhesion and high bacterial loads within the host, consequently increasing ST258 virulence. CrrAB also drives high antibiotic resistance in CR Kp . Thus, our data places CrrAB at the intersection of virulence and antibiotic resistance supporting its function as an important regulatory system driving the pathogenicity of ST258.